BioCatch

BioCatch is an operating company, not an investment firm. All strategic and financial decisions are managed by its internal leadership team, led by CEO Gadi Mazor. Greg Stockett, the Chief Financial Officer, oversees capital allocation and financial management. The firm has not publicly disclosed a formal investment committee or separate investment arm.

BioCatch captures behavioral telemetry directly from end-user interactions within its banking clients' digital applications. The system collects over 3,000 signals — including mouse dynamics, keystroke patterns, and navigation gestures — during live sessions. This data is processed via the firm's cloud platform, which applies behavioral sequencing and machine-learning models trained on its corpus of more than 16 billion analyzed sessions.

The firm focuses almost exclusively on financial institutions — it states its technology protects digital banking customers. There is no public evidence of deployment in non-banking verticals such as healthcare, gaming, or government identity verification, though its behavioral sequencing models are technically sector-agnostic.

BioCatch presents itself as an independent entity with its own management team and board of directors. No public disclosure indicates a parent company, controlling shareholder, or prior spinout from an academic or corporate lab. The neurobiological foundations of its science, led by Chief Science Officer Itai Novick, appear to be internally developed.

BioCatch positions its behavioral-intelligence signal as a complementary layer, not a replacement for a bank's existing fraud controls. The platform is designed to deliver a real-time risk score that banks can feed into their own decision engines, case-management systems, and step-up-authentication flows to add a behavioral-intent dimension to transaction risk analysis.